Last reviewed · How we verify
Therapeutic opioid induced constipation
Approved treatments
- Relistor · Salix Pharms
Relistor works by blocking opioid receptors in the gut to alleviate constipation. - Symproic · Bdsi
Symproic works by blocking the mu-type opioid receptor, which is responsible for slowing down bowel movements. - Naltrexon · Institute of Liver and Biliary Sciences, India
- Movantik · AstraZeneca
- Movantik · Averitas
Movantik works by blocking the mu-type opioid receptor, which is responsible for the constipating effects of opioids.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Therapeutic opioid induced constipation patent landscape — cliff calendar, originator estates, attackable patents
- Therapeutic opioid induced constipation treatment landscape brief
- Therapeutic opioid induced constipation treatment updates RSS
Frequently asked questions about Therapeutic opioid induced constipation
What drugs treat Therapeutic opioid induced constipation?
Tracked treatments include Relistor, Symproic, Naltrexon, Movantik.
What is the treatment for Therapeutic opioid induced constipation?
Standard treatment for Therapeutic opioid induced constipation includes Relistor, Symproic, Naltrexon, Movantik. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Therapeutic opioid induced constipation patent cliff · Therapeutic opioid induced constipation CI report
- Treatment: Relistor · Salix Pharms
- Treatment: Symproic · Bdsi
- Treatment: Naltrexon · Institute of Liver and Biliary Sciences, India
- Treatment: Movantik · AstraZeneca
- Treatment: Movantik · Averitas
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing